test
activ
infect
fundament
tool
public
health
measur
taken
control
pandem
due
overwhelm
use
rtpcr
test
worldwid
avail
test
kit
becom
major
bottleneck
demonstr
reliabl
effici
two
simpl
pool
strategi
increas
test
capac
popul
low
infect
rate
implement
method
routin
clinic
diagnosi
set
alreadi
test
individu
use
rna
extract
rtpcr
kit
emerg
novel
sever
acut
respiratori
syndromerel
coronaviru
viru
behind
global
pandem
among
foremost
prioriti
facilit
effici
public
health
intervent
reliabl
access
diagnosi
activ
infect
standard
laboratori
diagnosi
involv
three
main
step
name
viral
inactiv
lysi
nasopharyng
swab
sampl
extract
purif
viral
rna
revers
transcript
rt
pcr
due
rapid
spread
viru
increas
demand
test
limit
avail
test
reagent
mainli
rna
extract
kit
becom
like
continu
major
bottleneck
pandem
expand
particular
import
abil
survey
larg
asymptomat
popul
trace
asymptomat
carrier
otherwis
difficult
identifi
isol
assur
key
personnel
eg
healthcar
personnel
contagi
accur
estim
spread
infect
effect
commun
measur
social
distanc
allow
monitor
safe
return
work
clearli
effici
higherthroughput
diagnost
approach
need
support
effort
sever
attempt
address
challeng
alreadi
suggest
categor
three
major
approach
first
approach
replac
pcr
base
method
direct
diagnost
method
loopmedi
isotherm
amplif
lamp
crispr
base
diagnost
tool
second
approach
involv
serolog
survey
third
approach
involv
improv
pcr
method
capac
optim
autom
eg
reduc
requir
number
test
via
pool
sampl
togeth
known
group
test
group
test
field
research
intersect
mathemat
comput
scienc
inform
theori
applic
biolog
commun
group
test
algorithm
test
scheme
direct
toward
minim
number
test
conduct
set
sampl
use
abil
test
pool
subset
sampl
pool
n
sampl
test
neg
sampl
must
neg
therefor
statu
determin
one
test
instead
n
individu
test
variou
group
test
algorithm
exist
differ
assumpt
constraint
see
mani
algorithm
notabl
binari
split
may
effici
theori
might
unsuit
practic
limit
three
limit
might
limit
number
stage
due
import
deliv
test
result
quickli
exemplifi
urgent
clinic
context
diagnosi
limit
abil
dilut
sampl
still
safe
identifi
singl
posit
sampl
pool
favor
simpl
algorithm
may
minim
human
error
laboratori
set
sever
pool
approach
detect
recent
suggest
eg
none
demonstr
adher
current
clinic
standard
shown
work
perform
rna
extract
pool
typic
limit
step
describ
demonstr
practic
pool
solut
save
time
reagent
perform
rna
extract
rtpcr
pool
sampl
unlik
suggest
larg
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
scale
pool
nonpcrbas
method
maintain
compar
sensit
therefor
method
compli
current
clinic
requir
simplic
method
similar
current
approv
procedur
fact
requir
special
sampl
handl
addit
inform
make
easili
adopt
larg
scale
offer
two
pool
approach
base
either
simpl
dorfman
pool
matrix
pool
demonstr
effici
sensit
daili
realiti
clinic
case
current
clinic
diagnosi
paramet
method
allow
increas
throughput
appli
popul
posit
includ
screen
asymptomat
healthcar
personnel
essenti
industri
employe
hadassah
medic
center
two
distinct
popul
peopl
test
present
first
receiv
sampl
symptomat
patient
hospit
commun
sampl
test
posit
second
receiv
sampl
prospect
screen
asymptomat
popul
hospit
employe
worker
essenti
industri
among
latter
individu
test
sampl
reveal
rate
posit
rang
base
find
examin
feasibl
pool
test
asymptomat
popul
design
appropri
pool
strategi
key
requir
pool
rna
extract
rtpcr
test
retain
suffici
sensit
rtpcr
assay
sampl
defin
posit
viral
genom
detect
threshold
cycl
ct
valu
howev
reproduc
rna
extract
rtpcr
might
affect
factor
therefor
empir
test
assay
sensit
multipl
neg
sampl
one
posit
sampl
mix
lysat
stage
shown
figur
posit
sampl
readili
detect
even
individu
ct
rang
thu
rna
reliabl
detect
pool
sampl
without
compromis
assay
sensit
first
pool
strategi
simpl
twostag
test
algorithm
known
dorfman
pool
first
stage
sampl
divid
disjoint
pool
n
sampl
pool
test
neg
result
impli
sampl
pool
neg
posit
result
impli
least
one
sampl
pool
posit
second
stage
sampl
pool
test
posit
individu
test
approach
recent
suggest
eg
test
direct
pool
lysat
clinic
nasopharyng
sampl
rna
extract
alreadi
perform
pool
sampl
first
test
pool
consecut
sampl
pool
sampl
also
test
parallel
sampl
individu
approach
yield
highli
accur
result
loss
diagnost
assay
sensit
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
pool
contain
one
posit
sampl
found
posit
pool
contain
neg
sampl
found
neg
figur
pool
contain
one
individu
sampl
indetermin
result
pool
one
found
neg
suggest
potenti
yet
neglig
loss
sensit
pool
contain
singl
indetermin
sampl
detect
indetermin
pool
pool
contain
sampl
low
amount
detect
similar
ct
pool
show
clinic
sensit
retain
risk
fals
neg
minim
ud
undetect
reduc
need
retest
posit
pool
also
test
twostag
matrix
pool
strategi
n
sampl
order
n
x
n
matrix
row
column
pool
result
test
time
less
test
individu
test
either
number
posit
row
column
one
posit
sampl
uniqu
identifi
intersect
posit
row
column
otherwis
number
posit
row
column
greater
one
intersect
posit
row
column
retest
individu
test
approach
pool
sampl
three
x
matric
identifi
posit
sampl
accur
figur
importantli
posit
sampl
detect
row
column
pool
similar
cycl
three
test
matric
suggest
pool
scheme
robust
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
given
success
valid
pool
strategi
adopt
dorfman
pool
protocol
employ
routin
test
nasopharyng
swab
sampl
screen
asymptomat
healthcar
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
personnel
employe
essenti
industri
individu
barcod
sampl
receiv
laboratori
inactiv
lysi
buffer
pool
tecan
liquidhandl
robot
pool
process
qiasymphoni
robot
rna
extract
analyz
rtpcr
result
interpret
sampl
posit
pool
subsequ
individu
test
note
analysi
pool
result
requir
close
attent
indeterminateresult
pool
show
signal
ct
may
contain
individu
posit
sampl
therefor
criteria
retest
pool
must
stringent
eg
signal
ct
would
defin
neg
individu
sampl
test
warrant
retest
individu
sampl
encount
pool
see
tabl
batch
time
submiss
manuscript
alreadi
test
sampl
pool
therebi
use
rna
extract
rtpcr
reaction
mere
kit
would
use
full
individu
test
among
sampl
identifi
individu
valid
five
posit
sampl
correspond
rate
tabl
import
consider
implement
group
test
expect
rate
fals
posit
fals
neg
result
base
experi
sampl
asymptomat
individu
encount
fals
posit
pool
shown
figur
tabl
fals
neg
principl
worrisom
test
pool
sampl
fail
rna
extract
step
miss
individu
test
includ
amplif
human
transcript
serv
intern
control
proper
rna
extract
rtpcr
sampl
defin
magnitud
potenti
problem
examin
set
test
done
center
expect
show
signal
human
gene
serv
intern
assay
control
amplif
human
gene
fail
sampl
case
thu
estim
current
protocol
pool
sampl
carri
risk
miss
posit
sampl
popul
individu
test
posit
rate
predict
posit
individu
miss
use
pool
posit
toler
situat
particularli
given
potenti
much
higher
rate
fals
neg
result
due
swab
sampl
error
upstream
defin
effici
pool
algorithm
total
number
sampl
divid
expect
number
test
conduct
assum
sampl
independ
ident
distribut
denot
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
probabl
sampl
posit
p
preval
detect
patient
relev
popul
pool
size
n
effici
algorithm
describ
depend
p
n
best
theoret
effici
effici
dorfman
pool
chose
pool
size
sampl
allow
low
fals
neg
rate
figur
high
effici
wide
rang
preval
tabl
preval
detect
asymptomat
popul
estim
consider
inde
asymptomat
subject
test
present
studi
found
posit
therefor
effici
like
higher
preval
effici
matrix
pool
somewhat
higher
see
tabl
supplementari
note
provid
tool
http
githubcommatanseidelpoolingoptim
help
choos
approach
pool
size
base
preval
even
matrix
pool
effici
may
benefit
significantli
reduc
need
retest
provid
addit
confid
sampl
neg
detect
neg
two
pool
case
sampl
independ
inform
regard
depend
tri
effici
group
togeth
depend
sampl
sampl
like
posit
neg
member
famili
sampl
like
neg
sinc
low
risk
profil
increas
number
neg
pool
therefor
decreas
overal
number
test
conduct
preval
test
popul
alway
known
could
affect
optim
pool
size
could
address
either
extern
estim
previou
run
individu
sampl
rate
symptomat
patient
altern
method
serolog
screen
wastewat
titer
monitor
altern
possibl
dynam
adapt
pool
size
measur
rate
posit
sampl
differ
expect
final
exist
group
test
algorithm
purpos
estim
number
posit
sampl
use
rel
small
logarithm
amount
test
algorithm
may
adapt
clinic
constraint
paramet
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
futur
improv
sensit
test
better
set
primer
improv
sampl
collect
inclus
inform
pretest
probabl
allow
retain
sensit
even
pool
larg
number
sampl
lysat
togeth
enabl
improv
effici
especi
preval
low
increas
pool
size
summari
demonstr
reallif
situat
use
pool
sampl
start
earli
lysat
stage
allow
reliabl
effici
screen
larg
asymptomat
popul
presenc
infect
even
rna
extract
rtpcr
reagent
short
suppli
nasopharyng
swab
sampl
collect
ml
viral
transport
medium
vtm
mix
concentr
zymo
lysi
buffer
collect
directli
ml
zymo
lysi
buffer
initi
valid
sampl
collect
symptomat
patient
screen
healthi
asymptomat
subject
sampl
lysat
prepar
sampl
vtm
ad
lysi
buffer
rna
extract
use
magna
pure
kit
roch
lifesci
use
roch
platform
elut
ten
rna
use
reaction
use
realtim
fluoresc
rtpcr
kit
bgi
matrix
pool
design
pool
equal
volum
sampl
lysat
subject
final
volum
use
magna
pure
kit
roch
lifesci
use
roch
platform
suppli
limit
kit
use
qiasymphoni
dsp
viruspathogen
kit
qiasymphoni
platform
pool
design
pool
equal
volum
sampl
lysat
subject
final
volum
posit
pool
valid
singl
test
use
qiasymphoni
rna
kit
qiasymphoni
platform
qiagen
kit
use
zymo
lysi
buffer
therefor
skip
lysi
proteinas
k
step
rna
elut
rna
use
reaction
use
realtim
fluoresc
rtpcr
kit
bgi
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
